查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
白內障手術器械市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)
市場調查報告書
商品編碼
1190243

白內障手術器械市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Cataract Surgery Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計在 2022 年至 2027 年的預測期內，白內障手術器械市場的複合年增長率為 4.2%。

COVID-19 大流行不僅擾亂了 COVID-19 以外的其他治療方法和藥物的研發活動，而且還擾亂了世界各地的治療方案以及藥物和醫療設備供應鏈。它已經對白內障手術設備市場也有影響。 例如，根據 2021 年 12 月發表的題為“COVID-19 大流行影響白內障手術量”的研究“COVID-19 大流行對白內障手術量的影響”。 根據北印度經驗，接受調查的診所計劃進行 7,500 次白內障手術，但由於大流行，只有 2,500 次能夠進行。 數據顯示，在 COVID-19 大流行期間，白內障手術顯著減少。 然而，由於疫苗接種計劃的進展和 COVID-19 病例的減少，研究中的市場有望在研究預測期內恢復其全部潛力。

預計將推動白內障手術器械市場增長的主要因素是白內障患病率的增加和世界人口老齡化的加劇。 例如，根據 Xiaotong Han 等人發表的研究結果。 到 2021 年 9 月，全球白內障相關視力障礙患病率將從 1990 年的每 10 萬人 791.4 人增加到 2019 年的每 10 萬人 1253.9 人，增加 58.45%，這意味著白內障相關的殘疾調整生命年 (DALYs) 增加了 58.45%從1990年的每10萬人65.3人增加了32.18%到2019年的每10萬人86.3人，表明全球白內障和白內障相關疾病的增加。因此，可以看出白內障手術治療設備的需求正在增加，推動了增長的研究市場。

此外，根據 Konrad Pesudovs 等人於 2021 年 6 月發表的一項研究報告，到 2020 年，估計有 1520 萬 50 歲以上的人將失明，另有 7880 萬人將患有中度至重度白內障. 報導自 2000 年以來白內障失明的發病率增加了 29.7%，MSVI 病例增加了 93.1%。 因此，預計治療白內障的手術數量將逐年增加，這有望在預測期內推動白內障手術器械市場的增長。

此外，眾所周知，老年人白內障的患病率較高，隨著人口老齡化，白內障負擔預計將進一步增加，這有利於白內障手術器械市場的增長。產生影響。 例如，根據世界衛生組織 2021 年 10 月的更新，全球 60 歲及以上人口的比例將從 2015 年的 12% 增加到 2050 年的 22%，其中約 80% 據稱生活在中低收入人群- 收入國家。 根據同一份文件，與衰老相關的常見健康狀況包括聽力損失、白內障和屈光不正，以及背痛和頸部疼痛。 此外，預計眼科醫療設備的技術進步將在預測期內進一步推動監控市場的增長。 然而，與白內障設備和手術相關的高成本預計將在研究預測期內限制白內障手術設備市場的增長。

主要市場趨勢

在白內障手術器械市場，超聲乳化器械細分市場預計在預測期內佔據較大份額

超聲波乳化機是目前治療白內障最先進的設備之一，利用超聲波乳化機，可以將晶狀體用超聲波乳化，然後吸出。 在白內障手術中，白內障手術是使用每秒振動超過 40,000 次的鈦針通過 2.5 至 2.8 毫米的切口進行的。

超聲乳化裝置由於其相對於其他白內障手術的多項優勢而在全球範圍內廣泛應用於眼科，白內障負擔的增加導致其使用量有望進一步增加，這將推動該領域的增長。 白內障手術白內障超聲乳化的主要優點是手術無需住院，不易因切口小而誘發散光，手術恢復快，日常生活不受限制。 因此，白內障手術首選超聲乳化術。

此外，該領域領先公司在超聲乳化系統方面的進步，以及新設備的推出，與其他公司在產品開發和營銷方面的合作和夥伴關係，以及其他業務擴展努力，預計將推動增長的研究部分。 例如，2021 年 7 月，Johnson & Johnson Medical Devices Companies 旗下的 Johnson & Johnson Vision 將旨在解決三個關鍵領域：患者安全、外科醫生效率和舒適度。宣布 VERITAS Vision System，下一代超聲乳化（超聲乳化）系統。 因此，由於上述因素，預計在本研究的預測期內，超聲乳化設備部分將佔白內障手術設備市場的主要份額。

在預測期內，預計北美地區將佔據白內障手術器械市場的很大份額

按地區劃分，由於白內障的沉重負擔、先進和強大的醫療基礎設施的存在以及人口老齡化的加劇等因素，預計北美地區將佔據白內障手術設備市場的很大份額。是 例如，根據 2022 年 1 月的研究《加拿大視力障礙發病率：加拿大老齡化縱向研究》，加拿大白內障的發病率為 10.38%，不列顛哥倫比亞省的患病率最高，為 11.26%。隨著該國老齡化人口的增加，預計加拿大的負擔將進一步增加，從而隨著該國老齡化人口的增加而增加該地區的白內障負擔。這將導致白內障手術的增加，從而推動白內障手術器械市場的增長。

在北美地區，美國有望佔據白內障手術市場的很大份額。 這是由於該國強大的醫療基礎設施、更好的報銷政策以及不斷增長的老年人口導致的白內障負擔沉重，導致該國白內障手術數量眾多。 例如，根據美國疾病控制與預防中心 (CDC) 2020 年 6 月更新，約有 2050 萬 40 歲以上的人（約佔人口的 17.2%）的一隻或雙眼患有白內障，到 2020 年底2020 預計到 2020 年，白內障總人數將增加到 3010 萬，預計這將對國內進行的白內障手術數量產生重大影響，並推動監測市場的增長。 此外，隨著該國老齡化率的上升，美國白內障手術器械市場有望在預測期內增長。 因此，在北美地區，由於上述因素，預計在本研究的預測期內，美國將在白內障手術器械市場佔據重要市場份額。

競爭格局

白內障手術設備市場與幾家主要參與者保持適度競爭。 此外，由於新技術的進步以及新產品和新舉措的推出，預計市場競爭將加劇。 主要的市場領先公司包括 Coburn Technologies Inc.、Alcon Surgical Resources、Johnson & Johnson、NIDEK、Abbott、Ziemer Ophthalmic Systems、Carl Zeiss Meditech AG、Alcon, Inc.。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 白內障患病率上升和老年人口增加
    • 眼科設備技術進步
  • 市場製約因素
    • 白內障手術費用高昂
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第五章市場細分（價值基礎，單位：百萬美元）

  • 按產品類型
    • 人工晶狀體
    • 超聲波乳化抽吸裝置
    • 用於眼科的粘彈性裝置
    • 其他
  • 最終用戶
    • 眼科診所
    • 醫院
    • 其他
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Alcon, Inc.
    • Johnson & Johnson
    • Nidek Co., Ltd.
    • HAAG-Streit Holding AG
    • Ziemer Ophthalmic Systems
    • Carl Zeiss Meditech AG
    • Bausch & Lomb, Inc.
    • Iridex Corporation（Topcorn Corporation）
    • STAAR Surgical Company
    • Coburn Technologies Inc.
    • HumanOptics AG
    • GlaUnited Kingdomos Corporation
    • Sonomed Escalon

第7章 市場機會今後動向

簡介目錄
Product Code: 71260

The cataract surgery devices market is expected to register a CAGR of 4.2% during the forecast period of 2022-2027.

The COVID-19 pandemic led to disruption in not only the research and development activities of other therapies and drugs for medical conditions other than COVID-19 but also impacted the treatment procedures and supply chain of the pharmaceuticals and medical devices around the world, which also impacted the cataract surgery devices market. For instance, according to a research study published in December 2021, titled "Impact of COVID-19 Pandemic on Cataract Surgical Volume: A North Indian Experience", the studied clinic was expected to perform 7,500 cataract procedures, but due to the pandemic, they were able to perform only 2,500 procedures. This data suggests that there was a significant decrease in cataract procedures during the COVID-19 pandemic. However, with the ongoing vaccination programs and decreasing COVID-19 cases, the studied market is expected to regain its full potential over the forecast period of the study.

The major factors that are expected to drive growth in the cataract surgery devices market are the increasing prevalence of the cataract and the growing geriatric population globally. For instance, according to the research study published by Xiaotong Han et al., in September 2021, the global prevalence rate of cataract-related visual impairment increased by 58.45%, from 791.4 per 100,000 people in 1990 to 1,253.9 per 100,000 people in 2019, and the cataract-related disability-adjusted life years (DALYs) rate increased by 32.18 percent from 65.3 per 100,000 people in 1990 to 86.3 per 100,000 people in 2019, which shows an increase in cataract and cataract related illness, globally and thus, the demand for cataract surgery devices for treatment is increasing which is fueling growth in the studied market.

Further, according to the research study published by Konrad Pesudovs et. a., in June 2021, 2020, an estimated 15.2 million people aged 50 and more were blind, with another 78.8 million suffering from moderate to severe vision impairment (MSVI) due to cataract, and since 2000, there has been a 29.7% increase in the incidence of cataract blindness and a 93.1 percent increase in cases of MSVI. Hence, the number of surgeries for the treatment of cataracts is expected to increase over the years, which will drive growth in the cataract surgery devices market over the forecast period.

Moreover, the prevalence of cataracts is found to be higher in the older population, and with the growing geriatric population, the burden of cataracts is further expected to increase, which will have a positive impact on the growth of the cataract surgery devices market. For instance, according to the October 2021 update of the World Health Organization, the percentage of people of age more than 60 years in the global population will increase from 12% in 2015 to 22% by 2050, of which about 80% of the older people in 2050 will be living in the low-and middle-income countries. Also, as per the same source, the common heath conditions associated with aging includes hearing loss, cataracts and refractive errors, back and neck pain, and other. Also, technological advancements in ophthalmic devices are further expected to augment growth in the studied market over the forecast period of the study. However, the high cost associated with cataract devices and surgeries is expected to restrain growth in the cataract surgery devices market during the forecast period of the study.

Key Market Trends

Phacoemulsification Equipment Segment is Expected to Hold a Significant Share in the Cataract Surgery Devices Market Over the Forecast Period

Phacoemulsification systems are one of the most advanced types of equipment used in treating cataracts, and by using phacoemulsification equipment, the lens is emulsified with ultrasound before being suctioned out. With the help of phacoemulsification equipment, cataract surgery is performed through a 2.5 to 2.8 mm incision with the help of a titanium needle vibrating at the rate of more than 40,000 times per second.

The phacoemulsification systems offer several advantages over other cataract surgery procedures due to which this equipment is widely used in ophthalmology settings around the world, and with the increasing burden of cataracts, their usage is further expected to increase, which will boost growth in the segment. Some of the major benefits offered by phacoemulsification equipment in cataract surgery are no hospitalization required for surgery, small incision and lesser induced astigmatism because of the smaller incision, fast recovery from the surgery, and no restriction in daily routine. Hence, owing to these benefits, payers, and providers prefer a phacoemulsification system in cataract surgery.

In addition, the advancement in the phacoemulsification system by the key companies in the area along with the launch of new devices, collaboration, and partnerships with other companies for the development and marketing of the products, and other business expansion initiatives are expected to boost growth in the studied segment. For instance, in July 2021, Johnson & Johnson Vision, a part of the Johnson & Johnson Medical Devices Companies launched VERITAS Vision System, next-generation phacoemulsification (phaco) system designed to address three critical areas: patient safety, surgeon efficiency, and comfort. Therefore, due to these above-mentioned factors, the phacoemulsification equipment segment is expected to have a major share in the cataract surgery devices market during the forecast period of the study.

North America region is Expected to Occupy a Significant Share in the Cataract Surgery Devices Market Over the Forecast Period

By geography, the North American region is expected to hold a significant share in the cataract surgery devices market owing to the high burden of cataracts in the region, presence of advanced and robust healthcare infrastructure, growing aging population, and other factors. For instance, according to a research study in January 2022, titled "Incidence of visual impairment in Canada: the Canadian Longitudinal Study on Aging", the incidence of cataracts in Canada was 10.38%, with British Colombia being the region with the highest prevalence of 11.26% and the burden of cataract in Canada is further expected to increase with the growing geriatric population in the country, and hence with the growing geriatric population in the region, the burden of cataract is further expected to increase, leading to increase in several cataract surgeries and thus, driving growth in the cataract surgery devices market.

In the North American region, United States is expected to hold a major share in the cataract surgery devices market owing to a large number of cataract surgeries performed in the country due to its robust healthcare infrastructure, better reimbursement policies, and significant burden of cataract along with growing geriatric population. For instance, according to the June 2020 update of the Centers for Disease Control and Prevention (CDC), approximately 20.5 million (about 17.2% of the total population) of age 40 years and more had cataracts in one or both eyes, and it was estimated that by the end of 2020, the total number of people who have cataracts is estimated to increase to 30.1 million, which is expected to have a significant impact on the number of cataract surgeries performed in the country and boost growth in the studied market. Further, with the growing aging population of the country, the cataract surgery devices market in United States is expected to grow over the forecast period. Therefore, due to the above-mentioned factors, in the North American region, United States is expected to have a significant market share in the cataract surgery devices market during the forecast period of the study.

Competitive Landscape

The cataract surgery devices market is moderately competitive, with several major players in the area. Also, the new technological advancements and launch of new products and initiatives are expected to make the market more competitive. Some of the key companies leading the market are Coburn Technologies Inc., Alcon Surgical Resources, Johnson & Johnson, NIDEK, Abbott, Ziemer Ophthalmic Systems, Carl Zeiss Meditech AG, and Alcon, Inc., among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increase in Prevalence of Cataract Diseases and Increasing Geriatric Population
    • 4.2.2 Technological Advancements in Ophthalmic Devices
  • 4.3 Market Restraints
    • 4.3.1 High Cost Incurred for Cataract Surgeries
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - in USD Million)

  • 5.1 By Product Type
    • 5.1.1 Intraocular Lenses
    • 5.1.2 Phacoemulsification Equipment
    • 5.1.3 Ophthalmic Viscoelastic Devices
    • 5.1.4 Others
  • 5.2 By End-User
    • 5.2.1 Ophthalmology Clinics
    • 5.2.2 Hospitals
    • 5.2.3 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Alcon, Inc.
    • 6.1.2 Johnson & Johnson
    • 6.1.3 Nidek Co., Ltd.
    • 6.1.4 HAAG-Streit Holding AG
    • 6.1.5 Ziemer Ophthalmic Systems
    • 6.1.6 Carl Zeiss Meditech AG
    • 6.1.7 Bausch & Lomb, Inc.
    • 6.1.8 Iridex Corporation (Topcorn Corporation)
    • 6.1.9 STAAR Surgical Company
    • 6.1.10 Coburn Technologies Inc.
    • 6.1.11 HumanOptics AG
    • 6.1.12 Glaukos Corporation
    • 6.1.13 Sonomed Escalon

7 MARKET OPPORTUNITIES AND FUTURE TRENDS